Skip to main content

Hereditary cerebral amyloid angiopathy

Hereditary cerebral amyloid angiopathy is a condition characterised by an abnormal buildup of protein clumps called amyloid deposits in the blood vessels in the brain, causing vascular disease (angiopathy). People with hereditary cerebral amyloid angiopathy often have progressive loss of intellectual function (dementia), stroke, and other neurological problems starting in mid-adulthood. Due to neurological decline, this condition is typically fatal in one's sixties, although there is variation depending on the severity of the signs and symptoms. Most affected individuals die within a decade after signs and symptoms first appear, although some people with the disease have survived longer.

Description

Hereditary cerebral amyloid angiopathy is a condition characterised by an abnormal buildup of protein clumps called amyloid deposits in the blood vessels in the brain, causing vascular disease (angiopathy). People with hereditary cerebral amyloid angiopathy often have progressive loss of intellectual function (dementia), stroke, and other neurological problems starting in mid-adulthood. Due to neurological decline, this condition is typically fatal in one's sixties, although there is variation depending on the severity of the signs and symptoms. Most affected individuals die within a decade after signs and symptoms first appear, although some people with the disease have survived longer.

There are many different types of hereditary cerebral amyloid angiopathy. The different types are distinguished by their genetic cause, which determines whether areas of the brain other than blood vessels are affected, and the signs and symptoms that occur. The various types of hereditary cerebral amyloid angiopathy are named after the regions where they were first diagnosed.

The Dutch type of hereditary cerebral amyloid angiopathy is the most common form. Stroke is frequently the first sign of the Dutch type and is fatal in about one third of people who have this condition. Survivors often develop dementia and have recurrent strokes. About half of individuals with the Dutch type who have one or more strokes will have recurrent seizures (epilepsy).

People with the Flemish and Italian types of hereditary cerebral amyloid angiopathy are prone to recurrent strokes and dementia. Individuals with the Piedmont type may have one or more strokes and typically experience impaired movements, numbness or tingling (paresthesias), confusion, or dementia.

The first sign of the Icelandic type of hereditary cerebral amyloid angiopathy is typically a stroke followed by dementia. Strokes associated with the Icelandic type usually occur earlier than the other types, with individuals typically experiencing their first stroke in their twenties or thirties.

Strokes are rare in people with the Arctic type of hereditary cerebral amyloid angiopathy, in which the first sign is usually memory loss that then progresses to severe dementia. Strokes are also uncommon in individuals with the Iowa type. This type is characterised by memory loss, problems with vocabulary and the production of speech, personality changes, and involuntary muscle twitches (myoclonus).

Two types of hereditary cerebral amyloid angiopathy, known as familial British dementia and familial Danish dementia, are characterised by dementia and movement problems. Strokes are uncommon in these types. People with the Danish type also have clouding of the lens of the eyes (cataracts) and deafness.

Inheritance patterns

The source lists the following possible inheritance patterns: Autosomal dominant. More than one pattern can apply in different cases.

Other names

Autosomal dominant cerebrovascular amyloidosis

CAA, familial

Cerebral amyloid angiopathy, familial

Cerebral amyloid angiopathy, genetic

HCHWA-D

HCHWA-I

Hereditary cerebral hemorrhage with amyloidosis-Dutch type

Hereditary cerebral hemorrhage with amyloidosis-Icelandic type

Patient picks for Genetic conditions

Related patient information and medicines

Muscle weakness

Patient information leaflet

Muscle weakness

Neurological conditions : Muscle weakness can be caused by cerebrovascular disease such as a stroke and brain haemorrhage and spinal injury. Spine-related conditions : When nerves are damaged as they emerge from the spine (su... The condition usually goes away after a few years but can become more progressive in some people. Amyloidosis involves.

Medication and treatment for dementia

Patient information leaflet

Medication and treatment for dementia

A tranquilliser or an antipsychotic medicine Antipsychotic medicines is sometimes pr... Research continues looking for new medicines to help with dementia and there is some promising research with drugs known as 'mabs' which are a form of immunotherapy. They target amyloid in the brain, which is part of the disease process that causes dementia,.

COVID-19

Patient information leaflet

COVID-19

COVID-19 is an infectious disease caused by a virus that was first identified in December 2019 in Wuhan, China. This leaflet deals with the symptoms, causes and treatment of COVID-19. What is COVID-19. COVID-19 is an infectious disease caused by a virus (SARS CoV-2). COVID-19 is short for "coronavirus disease 2019", because the disease was first.

Epilepsy

Patient information leaflet

Epilepsy

About 1 in 30 people in the UK develop epilepsy at some stage in their lives. It... Medication to control seizures usually works well for people with idiopathic epilepsy. There is probably a genetic link to idiopathic epilepsy in many people - see 'is epilepsy hereditary?' below. Some types of idiopathic epilepsy have now been renamed 'genetic.

Porphyria

Patient information leaflet

Porphyria

The porphyrias are a group of disorders in which there is a problem with the production of haem (also spelled heme) within the body. Haem is used to make haemoglobin in red blood cells. This is because each type can have different symptoms and effects on the body. Symptoms vary greatly and can include tummy (abdominal) pain, nervous system.

Myeloma

Patient information leaflet

Myeloma

Myeloma is a cancer that affects cells, called plasma cells, in the bone marrow. Bone marrow is the spongy tissue at the centre of some bones that produces the body's blood cells. Other symptoms include bone pain, breaks (fractures) due to bone damage, and kidney damage. In many cases, treatment with chemotherapy and other treatments can control.

Further reading and references

Article history

The information on this page is written and peer reviewed by qualified clinicians.
  • 11 Apr 2022 | Latest version
  • 1 Apr 2022 | Originally published

Join the conversation

Share your thoughts or experiences with others in our patient communities.

Disclaimer: The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.

Online pharmacy, treatments and health services

Simple access to trusted treatments and health services online.

Common conditions

Get help with common conditions through the NHS, without a GP appointment.

Book your free Pharmacy First appointment

Sign up to the Patient newsletter

Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.

Please enter a valid email address

By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.